Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Leishmaniasis, Visceral | 17 | 2014 | 99 | 2.670 |
Why?
|
Chagas Disease | 20 | 2022 | 167 | 2.640 |
Why?
|
Trypanosoma cruzi | 18 | 2022 | 206 | 1.890 |
Why?
|
Chagas Cardiomyopathy | 7 | 2015 | 71 | 0.990 |
Why?
|
Dracunculiasis | 3 | 2008 | 13 | 0.800 |
Why?
|
Malaria, Vivax | 3 | 2014 | 167 | 0.740 |
Why?
|
Plasmodium vivax | 4 | 2014 | 202 | 0.720 |
Why?
|
Trypanocidal Agents | 3 | 2020 | 41 | 0.700 |
Why?
|
Nitroimidazoles | 3 | 2020 | 117 | 0.640 |
Why?
|
Insect Vectors | 6 | 2015 | 134 | 0.630 |
Why?
|
Leishmaniasis, Cutaneous | 5 | 2021 | 136 | 0.630 |
Why?
|
Triatoma | 3 | 2015 | 10 | 0.620 |
Why?
|
Leishmania infantum | 3 | 2014 | 17 | 0.610 |
Why?
|
Insect Control | 3 | 2015 | 29 | 0.610 |
Why?
|
Histoplasma | 1 | 2017 | 39 | 0.590 |
Why?
|
Cyclic Nucleotide-Gated Cation Channels | 1 | 2017 | 38 | 0.590 |
Why?
|
Color Vision Defects | 1 | 2017 | 28 | 0.590 |
Why?
|
Endemic Diseases | 7 | 2009 | 191 | 0.590 |
Why?
|
Histoplasmosis | 1 | 2017 | 63 | 0.580 |
Why?
|
Primaquine | 2 | 2014 | 28 | 0.570 |
Why?
|
Retinal Rod Photoreceptor Cells | 1 | 2017 | 200 | 0.530 |
Why?
|
Plasmodium | 2 | 2014 | 247 | 0.530 |
Why?
|
Dog Diseases | 2 | 2014 | 141 | 0.440 |
Why?
|
Toxoplasmosis | 2 | 2005 | 93 | 0.440 |
Why?
|
Schistosomiasis | 4 | 2007 | 64 | 0.420 |
Why?
|
Antimalarials | 5 | 2014 | 907 | 0.420 |
Why?
|
Antigens, Protozoan | 5 | 2007 | 315 | 0.410 |
Why?
|
Brazil | 20 | 2021 | 1214 | 0.370 |
Why?
|
Immunocompromised Host | 2 | 2009 | 857 | 0.360 |
Why?
|
Disease Outbreaks | 7 | 2006 | 1759 | 0.350 |
Why?
|
Cat Diseases | 1 | 2009 | 31 | 0.350 |
Why?
|
Bangladesh | 9 | 2013 | 734 | 0.340 |
Why?
|
Prosthesis-Related Infections | 3 | 2020 | 486 | 0.330 |
Why?
|
Leishmania braziliensis | 2 | 2021 | 16 | 0.320 |
Why?
|
Health Facility Administration | 1 | 2008 | 29 | 0.320 |
Why?
|
Travel | 7 | 2017 | 786 | 0.320 |
Why?
|
Zoonoses | 1 | 2009 | 179 | 0.310 |
Why?
|
Life Cycle Stages | 3 | 2017 | 160 | 0.310 |
Why?
|
Albendazole | 2 | 2008 | 50 | 0.310 |
Why?
|
Strongyloidiasis | 1 | 2007 | 27 | 0.300 |
Why?
|
Taeniasis | 2 | 2005 | 15 | 0.290 |
Why?
|
Parotitis | 1 | 2007 | 28 | 0.290 |
Why?
|
Antibodies, Protozoan | 7 | 2011 | 250 | 0.290 |
Why?
|
Cyclosporiasis | 2 | 2005 | 4 | 0.270 |
Why?
|
Antiprotozoal Agents | 6 | 2013 | 94 | 0.270 |
Why?
|
Refugees | 3 | 2008 | 598 | 0.260 |
Why?
|
Skin Tests | 2 | 2006 | 637 | 0.260 |
Why?
|
Antifungal Agents | 2 | 2002 | 746 | 0.260 |
Why?
|
Malaria, Falciparum | 6 | 2010 | 1076 | 0.260 |
Why?
|
Antiparasitic Agents | 1 | 2005 | 43 | 0.250 |
Why?
|
Pregnancy Complications, Parasitic | 1 | 2005 | 61 | 0.250 |
Why?
|
Communicable Diseases | 2 | 2009 | 879 | 0.250 |
Why?
|
Abdominal Pain | 2 | 2008 | 1064 | 0.240 |
Why?
|
Arthritis, Infectious | 2 | 2020 | 345 | 0.240 |
Why?
|
Infectious Disease Transmission, Vertical | 2 | 2022 | 1349 | 0.240 |
Why?
|
Anticestodal Agents | 1 | 2004 | 3 | 0.240 |
Why?
|
Radioactive Hazard Release | 1 | 2004 | 13 | 0.230 |
Why?
|
Leishmaniasis, Mucocutaneous | 1 | 2003 | 14 | 0.230 |
Why?
|
AIDS-Related Opportunistic Infections | 3 | 2002 | 661 | 0.230 |
Why?
|
Guatemala | 3 | 2015 | 159 | 0.230 |
Why?
|
Influenza Vaccines | 2 | 2012 | 770 | 0.230 |
Why?
|
Gingival Diseases | 1 | 2003 | 36 | 0.220 |
Why?
|
Women's Health Services | 1 | 2004 | 89 | 0.220 |
Why?
|
Preventive Health Services | 1 | 2008 | 571 | 0.220 |
Why?
|
Rural Population | 9 | 2005 | 2267 | 0.220 |
Why?
|
Palate | 1 | 2003 | 124 | 0.220 |
Why?
|
Oral Ulcer | 1 | 2003 | 96 | 0.210 |
Why?
|
Indians, South American | 2 | 1999 | 34 | 0.210 |
Why?
|
Cyclospora | 1 | 2002 | 2 | 0.210 |
Why?
|
Neurocysticercosis | 1 | 2004 | 91 | 0.210 |
Why?
|
Leishmania major | 1 | 2002 | 59 | 0.200 |
Why?
|
Leishmania | 2 | 2008 | 75 | 0.190 |
Why?
|
Fluconazole | 1 | 2002 | 155 | 0.190 |
Why?
|
Sudan | 3 | 2007 | 86 | 0.190 |
Why?
|
Humans | 114 | 2023 | 760261 | 0.190 |
Why?
|
Trypanosomiasis, African | 2 | 2008 | 30 | 0.190 |
Why?
|
Disease Transmission, Infectious | 1 | 2006 | 558 | 0.180 |
Why?
|
Hemorrhagic Fever, American | 1 | 2000 | 12 | 0.180 |
Why?
|
Malaria | 4 | 2010 | 1226 | 0.180 |
Why?
|
Bursitis | 1 | 2021 | 80 | 0.180 |
Why?
|
Animals | 47 | 2015 | 167940 | 0.180 |
Why?
|
Insecticides | 2 | 2014 | 191 | 0.180 |
Why?
|
Lymphatic Diseases | 2 | 1995 | 319 | 0.180 |
Why?
|
Dental Caries | 1 | 2004 | 420 | 0.170 |
Why?
|
Chloroquine | 3 | 2014 | 277 | 0.170 |
Why?
|
Methylprednisolone | 1 | 2021 | 384 | 0.170 |
Why?
|
Dogs | 5 | 2014 | 3843 | 0.170 |
Why?
|
Amebiasis | 3 | 2005 | 33 | 0.170 |
Why?
|
Adult | 54 | 2023 | 219847 | 0.170 |
Why?
|
Amphotericin B | 1 | 1999 | 141 | 0.170 |
Why?
|
Brain Diseases | 2 | 2004 | 1540 | 0.160 |
Why?
|
Plasmodium falciparum | 6 | 2010 | 1741 | 0.160 |
Why?
|
Child, Preschool | 23 | 2013 | 42034 | 0.160 |
Why?
|
Disease Vectors | 2 | 2014 | 61 | 0.160 |
Why?
|
Onchocerciasis | 2 | 2007 | 28 | 0.160 |
Why?
|
Molecular Epidemiology | 2 | 2019 | 469 | 0.150 |
Why?
|
Pharmacy and Therapeutics Committee | 1 | 1998 | 9 | 0.150 |
Why?
|
Dengue | 1 | 2021 | 255 | 0.150 |
Why?
|
Carrier State | 1 | 2002 | 525 | 0.150 |
Why?
|
Itraconazole | 1 | 2017 | 43 | 0.150 |
Why?
|
Phenytoin | 2 | 1988 | 188 | 0.150 |
Why?
|
Bolivia | 2 | 2009 | 22 | 0.150 |
Why?
|
Liver Cirrhosis | 1 | 2008 | 1925 | 0.150 |
Why?
|
Prevalence | 10 | 2023 | 15687 | 0.150 |
Why?
|
Bronchoalveolar Lavage | 1 | 2017 | 129 | 0.140 |
Why?
|
Sodium Chloride | 1 | 1999 | 596 | 0.140 |
Why?
|
Knee Prosthesis | 1 | 2020 | 394 | 0.140 |
Why?
|
Child | 34 | 2013 | 79758 | 0.140 |
Why?
|
Babesia microti | 1 | 2017 | 31 | 0.140 |
Why?
|
Infant | 18 | 2022 | 36030 | 0.140 |
Why?
|
Pulmonary Edema | 1 | 1999 | 409 | 0.140 |
Why?
|
Dark Adaptation | 1 | 2017 | 221 | 0.140 |
Why?
|
Diagnosis, Differential | 4 | 2017 | 12968 | 0.140 |
Why?
|
Female | 49 | 2023 | 391011 | 0.130 |
Why?
|
Ghana | 2 | 2008 | 312 | 0.130 |
Why?
|
Fever | 2 | 2014 | 1618 | 0.130 |
Why?
|
Leishmaniasis | 2 | 2008 | 66 | 0.130 |
Why?
|
Babesiosis | 1 | 2017 | 92 | 0.130 |
Why?
|
Disease Reservoirs | 2 | 2010 | 121 | 0.130 |
Why?
|
El Salvador | 1 | 2015 | 34 | 0.130 |
Why?
|
Honduras | 1 | 2015 | 37 | 0.130 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2009 | 3804 | 0.130 |
Why?
|
Hospitals, Urban | 1 | 1998 | 499 | 0.130 |
Why?
|
Electroretinography | 1 | 2017 | 518 | 0.130 |
Why?
|
Influenza, Human | 1 | 2007 | 1532 | 0.130 |
Why?
|
Medical Tourism | 1 | 2016 | 52 | 0.130 |
Why?
|
Consanguinity | 1 | 2017 | 456 | 0.130 |
Why?
|
Male | 52 | 2023 | 359413 | 0.130 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2017 | 146 | 0.130 |
Why?
|
Splenectomy | 1 | 2017 | 391 | 0.130 |
Why?
|
Lymph Nodes | 2 | 2017 | 3491 | 0.120 |
Why?
|
Mycobacterium Infections | 1 | 1995 | 121 | 0.120 |
Why?
|
Incidence | 11 | 2014 | 21378 | 0.120 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2019 | 612 | 0.120 |
Why?
|
Polymerase Chain Reaction | 6 | 2009 | 6067 | 0.120 |
Why?
|
Women's Health | 1 | 2004 | 2057 | 0.120 |
Why?
|
Adolescent | 27 | 2013 | 87747 | 0.120 |
Why?
|
Serologic Tests | 2 | 2007 | 383 | 0.120 |
Why?
|
Socioeconomic Factors | 5 | 2006 | 7803 | 0.110 |
Why?
|
Siblings | 1 | 2017 | 825 | 0.110 |
Why?
|
Mutation | 2 | 2017 | 29950 | 0.110 |
Why?
|
Surgical Wound Infection | 2 | 1996 | 1529 | 0.110 |
Why?
|
Sex Distribution | 4 | 2006 | 2295 | 0.110 |
Why?
|
Surgical Mesh | 1 | 1996 | 315 | 0.110 |
Why?
|
Models, Statistical | 2 | 2012 | 5073 | 0.110 |
Why?
|
Hypolipidemic Agents | 4 | 1990 | 626 | 0.110 |
Why?
|
Disease Susceptibility | 1 | 2019 | 1791 | 0.100 |
Why?
|
Electrocardiography | 9 | 2011 | 6413 | 0.100 |
Why?
|
Gastrointestinal Diseases | 1 | 2001 | 1189 | 0.100 |
Why?
|
Abdominal Injuries | 1 | 1996 | 362 | 0.100 |
Why?
|
Lung Diseases, Parasitic | 1 | 1991 | 14 | 0.100 |
Why?
|
Health Behavior | 1 | 2004 | 2621 | 0.100 |
Why?
|
Schistosoma mansoni | 4 | 2007 | 156 | 0.100 |
Why?
|
United States | 13 | 2022 | 72363 | 0.100 |
Why?
|
Medically Underserved Area | 2 | 2004 | 258 | 0.100 |
Why?
|
Bone Screws | 1 | 1995 | 529 | 0.100 |
Why?
|
Protozoan Proteins | 3 | 2007 | 838 | 0.100 |
Why?
|
Middle Aged | 32 | 2023 | 220175 | 0.090 |
Why?
|
Photic Stimulation | 1 | 2017 | 1968 | 0.090 |
Why?
|
Lung Diseases, Fungal | 1 | 1991 | 125 | 0.090 |
Why?
|
Seizures | 1 | 2004 | 2916 | 0.090 |
Why?
|
Anthelmintics | 2 | 2008 | 82 | 0.090 |
Why?
|
DNA, Protozoan | 2 | 2009 | 228 | 0.090 |
Why?
|
Immunoglobulin G | 5 | 2012 | 4546 | 0.090 |
Why?
|
Phenobarbital | 2 | 1990 | 190 | 0.090 |
Why?
|
Barbiturates | 1 | 1990 | 113 | 0.090 |
Why?
|
Prosthesis Failure | 1 | 1995 | 1206 | 0.090 |
Why?
|
Electromyography | 1 | 1995 | 1386 | 0.090 |
Why?
|
Macular Degeneration | 1 | 2017 | 1003 | 0.090 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2020 | 1403 | 0.090 |
Why?
|
Alcoholism | 1 | 2021 | 1961 | 0.090 |
Why?
|
Animals, Domestic | 2 | 2011 | 57 | 0.090 |
Why?
|
Cluster Analysis | 4 | 2009 | 2698 | 0.090 |
Why?
|
Altitude | 2 | 2004 | 159 | 0.080 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2020 | 1367 | 0.080 |
Why?
|
Risk Factors | 13 | 2020 | 74269 | 0.080 |
Why?
|
Poisson Distribution | 2 | 2008 | 507 | 0.080 |
Why?
|
Hip Prosthesis | 1 | 1995 | 920 | 0.080 |
Why?
|
Surgery, Plastic | 1 | 2016 | 640 | 0.080 |
Why?
|
Togo | 1 | 2008 | 8 | 0.080 |
Why?
|
Seasons | 3 | 2010 | 1523 | 0.080 |
Why?
|
Pregnancy Complications, Infectious | 2 | 2012 | 2127 | 0.080 |
Why?
|
Catechols | 1 | 1988 | 62 | 0.080 |
Why?
|
Disease Management | 1 | 2019 | 2508 | 0.080 |
Why?
|
Pyrethrins | 1 | 2008 | 44 | 0.080 |
Why?
|
Emigration and Immigration | 1 | 1991 | 395 | 0.080 |
Why?
|
Kidney Diseases | 1 | 1999 | 2093 | 0.080 |
Why?
|
Monitoring, Intraoperative | 1 | 1995 | 941 | 0.080 |
Why?
|
Seroepidemiologic Studies | 2 | 2007 | 393 | 0.080 |
Why?
|
Parasite Egg Count | 3 | 2006 | 29 | 0.080 |
Why?
|
Cats | 1 | 2009 | 976 | 0.080 |
Why?
|
Parasitemia | 3 | 2009 | 166 | 0.080 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2012 | 448 | 0.080 |
Why?
|
Autonomic Nervous System Diseases | 1 | 2011 | 269 | 0.080 |
Why?
|
Schistosoma haematobium | 1 | 2007 | 13 | 0.080 |
Why?
|
Onchocerca volvulus | 1 | 2007 | 15 | 0.080 |
Why?
|
Wolbachia | 1 | 2007 | 21 | 0.070 |
Why?
|
Antigens, Helminth | 1 | 2007 | 68 | 0.070 |
Why?
|
Urban Population | 3 | 2006 | 2021 | 0.070 |
Why?
|
Somalia | 1 | 2007 | 78 | 0.070 |
Why?
|
Helminthiasis | 1 | 2008 | 80 | 0.070 |
Why?
|
Aged | 23 | 2021 | 168995 | 0.070 |
Why?
|
Dermatitis, Contact | 1 | 1987 | 133 | 0.070 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2008 | 347 | 0.070 |
Why?
|
Joint Prosthesis | 1 | 1988 | 253 | 0.070 |
Why?
|
Leishmania mexicana | 1 | 2006 | 33 | 0.070 |
Why?
|
Americas | 1 | 2006 | 111 | 0.070 |
Why?
|
Oligodendroglioma | 1 | 2008 | 279 | 0.070 |
Why?
|
Antibodies | 6 | 1987 | 2424 | 0.070 |
Why?
|
Azithromycin | 1 | 2007 | 201 | 0.070 |
Why?
|
Age Factors | 6 | 2020 | 18415 | 0.070 |
Why?
|
Communicable Disease Control | 2 | 2009 | 844 | 0.070 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2008 | 635 | 0.060 |
Why?
|
Loss of Heterozygosity | 1 | 2008 | 659 | 0.060 |
Why?
|
Ascariasis | 1 | 2005 | 13 | 0.060 |
Why?
|
Trichinellosis | 1 | 2005 | 28 | 0.060 |
Why?
|
Autonomic Nervous System | 1 | 2011 | 697 | 0.060 |
Why?
|
Rifampin | 1 | 2007 | 341 | 0.060 |
Why?
|
Biopsy | 1 | 2017 | 6775 | 0.060 |
Why?
|
Spinal Fusion | 1 | 1995 | 1280 | 0.060 |
Why?
|
Giardiasis | 1 | 2005 | 28 | 0.060 |
Why?
|
Cysticercosis | 1 | 2005 | 35 | 0.060 |
Why?
|
Leishmania donovani | 1 | 2005 | 68 | 0.060 |
Why?
|
Oxamniquine | 4 | 1993 | 4 | 0.060 |
Why?
|
Cryptosporidiosis | 1 | 2005 | 55 | 0.060 |
Why?
|
Infant, Newborn | 8 | 2009 | 26168 | 0.060 |
Why?
|
Lobosea | 1 | 2004 | 2 | 0.060 |
Why?
|
Central Nervous System Protozoal Infections | 1 | 2004 | 6 | 0.060 |
Why?
|
Age Distribution | 3 | 2006 | 2893 | 0.060 |
Why?
|
United Nations | 1 | 2005 | 152 | 0.060 |
Why?
|
Peru | 4 | 2011 | 870 | 0.060 |
Why?
|
Nutrition Disorders | 2 | 2002 | 205 | 0.060 |
Why?
|
Radioactive Fallout | 1 | 2004 | 7 | 0.060 |
Why?
|
Bundle-Branch Block | 1 | 2006 | 281 | 0.060 |
Why?
|
Dental Anxiety | 1 | 2004 | 8 | 0.060 |
Why?
|
Taenia | 1 | 2004 | 17 | 0.060 |
Why?
|
Blotting, Southern | 2 | 2002 | 778 | 0.060 |
Why?
|
Awareness | 1 | 2008 | 644 | 0.060 |
Why?
|
DMF Index | 1 | 2004 | 87 | 0.060 |
Why?
|
Antimony Sodium Gluconate | 1 | 2003 | 11 | 0.060 |
Why?
|
Vitamin A | 1 | 2007 | 613 | 0.060 |
Why?
|
Parasites | 1 | 2006 | 162 | 0.060 |
Why?
|
Cameroon | 2 | 1997 | 76 | 0.060 |
Why?
|
Polymorphism, Restriction Fragment Length | 2 | 2002 | 761 | 0.060 |
Why?
|
Toxoplasma | 1 | 2005 | 151 | 0.060 |
Why?
|
Respiratory Tract Infections | 1 | 1991 | 1001 | 0.060 |
Why?
|
Topography, Medical | 2 | 2009 | 37 | 0.060 |
Why?
|
Ukraine | 1 | 2004 | 139 | 0.060 |
Why?
|
Anti-Bacterial Agents | 4 | 2016 | 7400 | 0.060 |
Why?
|
Nitriles | 1 | 2008 | 955 | 0.050 |
Why?
|
Anopheles | 2 | 2010 | 192 | 0.050 |
Why?
|
Feces | 5 | 2006 | 1466 | 0.050 |
Why?
|
Zinc | 1 | 2007 | 690 | 0.050 |
Why?
|
Esophageal Achalasia | 1 | 1984 | 94 | 0.050 |
Why?
|
Venezuela | 2 | 1999 | 75 | 0.050 |
Why?
|
DNA, Kinetoplast | 1 | 2002 | 12 | 0.050 |
Why?
|
HIV Infections | 3 | 2012 | 17159 | 0.050 |
Why?
|
Directly Observed Therapy | 1 | 2003 | 140 | 0.050 |
Why?
|
Sex Factors | 3 | 2010 | 10530 | 0.050 |
Why?
|
Sampling Studies | 1 | 2004 | 614 | 0.050 |
Why?
|
Severe Acute Respiratory Syndrome | 1 | 2003 | 137 | 0.050 |
Why?
|
Private Sector | 1 | 2005 | 398 | 0.050 |
Why?
|
Sensitivity and Specificity | 5 | 2012 | 14656 | 0.050 |
Why?
|
Recurrence | 1 | 2014 | 8487 | 0.050 |
Why?
|
Blastomycosis | 1 | 2001 | 14 | 0.050 |
Why?
|
Climate | 1 | 2002 | 147 | 0.050 |
Why?
|
Hepatitis C | 1 | 2012 | 1578 | 0.050 |
Why?
|
Communicable Diseases, Emerging | 1 | 2003 | 150 | 0.050 |
Why?
|
Phenotype | 1 | 2019 | 16543 | 0.050 |
Why?
|
Chromosome Aberrations | 1 | 2008 | 1767 | 0.050 |
Why?
|
Saudi Arabia | 1 | 2002 | 209 | 0.050 |
Why?
|
Geography | 1 | 2003 | 661 | 0.050 |
Why?
|
Myiasis | 1 | 2001 | 14 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 3 | 2017 | 20484 | 0.050 |
Why?
|
Transients and Migrants | 1 | 2004 | 162 | 0.050 |
Why?
|
Facial Dermatoses | 1 | 2001 | 85 | 0.050 |
Why?
|
Psychodidae | 1 | 2000 | 26 | 0.050 |
Why?
|
Antibodies, Viral | 1 | 2012 | 3145 | 0.050 |
Why?
|
Encephalitis | 1 | 2004 | 436 | 0.050 |
Why?
|
Agriculture | 1 | 2002 | 190 | 0.040 |
Why?
|
History, 16th Century | 1 | 2000 | 70 | 0.040 |
Why?
|
Digestive System | 1 | 2001 | 244 | 0.040 |
Why?
|
History, 17th Century | 1 | 2000 | 107 | 0.040 |
Why?
|
Melarsoprol | 1 | 1999 | 1 | 0.040 |
Why?
|
Myanmar | 2 | 2010 | 44 | 0.040 |
Why?
|
Intestinal Diseases, Parasitic | 1 | 2000 | 64 | 0.040 |
Why?
|
Injections, Intra-Articular | 1 | 2021 | 280 | 0.040 |
Why?
|
Reoperation | 2 | 2020 | 4292 | 0.040 |
Why?
|
Information Systems | 1 | 2002 | 398 | 0.040 |
Why?
|
Enteritis | 1 | 2001 | 162 | 0.040 |
Why?
|
Triatominae | 2 | 2011 | 6 | 0.040 |
Why?
|
Hip | 1 | 2021 | 250 | 0.040 |
Why?
|
Arthritis, Rheumatoid | 1 | 1995 | 3763 | 0.040 |
Why?
|
Abscess | 2 | 1996 | 605 | 0.040 |
Why?
|
History, 18th Century | 1 | 2000 | 207 | 0.040 |
Why?
|
Parasitic Diseases | 2 | 2006 | 76 | 0.040 |
Why?
|
Developing Countries | 3 | 2016 | 2880 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2007 | 15827 | 0.040 |
Why?
|
Pregnancy | 4 | 2012 | 29725 | 0.040 |
Why?
|
Attitude to Health | 1 | 2008 | 2028 | 0.040 |
Why?
|
World Health Organization | 1 | 2005 | 1319 | 0.040 |
Why?
|
Tropical Medicine | 1 | 1999 | 51 | 0.040 |
Why?
|
Antiretroviral Therapy, Highly Active | 2 | 2012 | 1894 | 0.040 |
Why?
|
Rain | 1 | 1999 | 61 | 0.040 |
Why?
|
Furosemide | 1 | 1999 | 170 | 0.040 |
Why?
|
Lung | 1 | 2017 | 9989 | 0.040 |
Why?
|
Sumatriptan | 1 | 1998 | 66 | 0.040 |
Why?
|
Meningeal Arteries | 1 | 1998 | 67 | 0.040 |
Why?
|
Chronic Disease | 3 | 2006 | 9283 | 0.040 |
Why?
|
Arthrodesis | 1 | 2020 | 186 | 0.040 |
Why?
|
Interdepartmental Relations | 1 | 1998 | 13 | 0.040 |
Why?
|
Hospital Bed Capacity, 500 and over | 1 | 1998 | 114 | 0.040 |
Why?
|
Drugs, Investigational | 1 | 2020 | 214 | 0.040 |
Why?
|
Facility Regulation and Control | 1 | 1998 | 24 | 0.040 |
Why?
|
Logistic Models | 2 | 2007 | 13311 | 0.040 |
Why?
|
Education, Pharmacy | 1 | 1998 | 38 | 0.040 |
Why?
|
Linear Models | 2 | 2008 | 5876 | 0.040 |
Why?
|
Receptors, Serotonin | 1 | 1998 | 208 | 0.040 |
Why?
|
Mexico | 1 | 2000 | 760 | 0.040 |
Why?
|
Demography | 1 | 2002 | 1650 | 0.040 |
Why?
|
Community Health Services | 1 | 2003 | 654 | 0.040 |
Why?
|
History, 19th Century | 1 | 2000 | 720 | 0.040 |
Why?
|
Formularies as Topic | 1 | 1998 | 93 | 0.040 |
Why?
|
Onchocerciasis, Ocular | 1 | 1997 | 7 | 0.040 |
Why?
|
Time Factors | 4 | 2009 | 40133 | 0.040 |
Why?
|
Organizational Case Studies | 1 | 1998 | 301 | 0.040 |
Why?
|
Program Evaluation | 1 | 2005 | 2494 | 0.030 |
Why?
|
Regression Analysis | 2 | 2007 | 6361 | 0.030 |
Why?
|
Aged, 80 and over | 7 | 2007 | 58947 | 0.030 |
Why?
|
Drug Utilization Review | 1 | 1998 | 251 | 0.030 |
Why?
|
Treatment Outcome | 6 | 2009 | 64947 | 0.030 |
Why?
|
Breast Feeding | 1 | 2005 | 1356 | 0.030 |
Why?
|
Fruit | 1 | 2002 | 1162 | 0.030 |
Why?
|
Rats, Inbred Strains | 4 | 1990 | 2094 | 0.030 |
Why?
|
Diuretics | 1 | 1999 | 612 | 0.030 |
Why?
|
Cost of Illness | 1 | 2006 | 1940 | 0.030 |
Why?
|
Certification | 1 | 1999 | 423 | 0.030 |
Why?
|
Vaccination | 1 | 2008 | 3360 | 0.030 |
Why?
|
Health Education | 1 | 2002 | 1049 | 0.030 |
Why?
|
Urinary Diversion | 1 | 1996 | 135 | 0.030 |
Why?
|
Organizational Policy | 1 | 1998 | 429 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 2 | 1983 | 2255 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2007 | 3822 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 1998 | 651 | 0.030 |
Why?
|
Spinal Nerve Roots | 1 | 1995 | 121 | 0.030 |
Why?
|
Toxoplasmosis, Congenital | 1 | 1994 | 8 | 0.030 |
Why?
|
Social Class | 1 | 2004 | 2005 | 0.030 |
Why?
|
Follow-Up Studies | 7 | 2002 | 39254 | 0.030 |
Why?
|
Syndrome | 1 | 2001 | 3278 | 0.030 |
Why?
|
Rural Health | 3 | 2006 | 299 | 0.030 |
Why?
|
Proportional Hazards Models | 3 | 2008 | 12532 | 0.030 |
Why?
|
Hip Joint | 1 | 2021 | 1006 | 0.030 |
Why?
|
Tuberculosis, Multidrug-Resistant | 1 | 2003 | 931 | 0.030 |
Why?
|
Ethanol | 1 | 2021 | 1323 | 0.030 |
Why?
|
Accreditation | 1 | 1998 | 477 | 0.030 |
Why?
|
Nitroquinolines | 2 | 1986 | 4 | 0.030 |
Why?
|
Antitubercular Agents | 1 | 2003 | 1374 | 0.030 |
Why?
|
Adverse Drug Reaction Reporting Systems | 1 | 1998 | 488 | 0.030 |
Why?
|
Trichlorfon | 1 | 1993 | 1 | 0.030 |
Why?
|
Synovitis | 1 | 1995 | 216 | 0.030 |
Why?
|
Pyrimethamine | 2 | 1994 | 94 | 0.030 |
Why?
|
Praziquantel | 1 | 1993 | 34 | 0.030 |
Why?
|
Anti-Infective Agents | 1 | 2001 | 982 | 0.030 |
Why?
|
Cross-Sectional Studies | 5 | 2004 | 25928 | 0.030 |
Why?
|
Postoperative Complications | 1 | 2016 | 15680 | 0.030 |
Why?
|
Mycobacterium avium Complex | 1 | 1993 | 59 | 0.030 |
Why?
|
Population Surveillance | 3 | 2010 | 2609 | 0.030 |
Why?
|
Gastrointestinal Neoplasms | 1 | 2001 | 951 | 0.030 |
Why?
|
Analysis of Variance | 1 | 2002 | 6242 | 0.030 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 1993 | 76 | 0.030 |
Why?
|
Triazoles | 1 | 1998 | 904 | 0.030 |
Why?
|
Debridement | 1 | 1996 | 492 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2008 | 12156 | 0.030 |
Why?
|
Bruch Membrane | 1 | 1993 | 65 | 0.030 |
Why?
|
Radiography | 3 | 2001 | 6965 | 0.030 |
Why?
|
Collagenases | 1 | 2013 | 221 | 0.030 |
Why?
|
Odds Ratio | 1 | 2005 | 9712 | 0.030 |
Why?
|
Base Sequence | 2 | 2002 | 12447 | 0.030 |
Why?
|
Caribbean Region | 1 | 1993 | 191 | 0.030 |
Why?
|
Hernia, Ventral | 1 | 1996 | 214 | 0.030 |
Why?
|
Prospective Studies | 6 | 2023 | 54263 | 0.030 |
Why?
|
Drug Costs | 1 | 2020 | 1184 | 0.020 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 1991 | 2197 | 0.020 |
Why?
|
United States Food and Drug Administration | 1 | 2020 | 1675 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 2002 | 4286 | 0.020 |
Why?
|
Latin America | 1 | 1993 | 405 | 0.020 |
Why?
|
Mothers | 1 | 2022 | 2186 | 0.020 |
Why?
|
Focal Infection | 1 | 1991 | 9 | 0.020 |
Why?
|
Indium Radioisotopes | 1 | 1991 | 113 | 0.020 |
Why?
|
Molecular Sequence Data | 2 | 2002 | 17628 | 0.020 |
Why?
|
Endometritis | 1 | 1991 | 49 | 0.020 |
Why?
|
Organ Transplantation | 1 | 2001 | 1150 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2002 | 4717 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2006 | 14482 | 0.020 |
Why?
|
Pentetic Acid | 1 | 1991 | 209 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 1995 | 1633 | 0.020 |
Why?
|
Drainage | 1 | 2016 | 1161 | 0.020 |
Why?
|
Electric Stimulation | 1 | 1995 | 1735 | 0.020 |
Why?
|
Luminol | 1 | 1989 | 6 | 0.020 |
Why?
|
Sulfadoxine | 1 | 1989 | 46 | 0.020 |
Why?
|
Neonatal Screening | 1 | 1994 | 595 | 0.020 |
Why?
|
Radioimmunoprecipitation Assay | 1 | 2009 | 16 | 0.020 |
Why?
|
Mycoses | 1 | 1993 | 387 | 0.020 |
Why?
|
Evoked Potentials | 1 | 1995 | 1031 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2004 | 3967 | 0.020 |
Why?
|
Phospholipids | 1 | 1993 | 789 | 0.020 |
Why?
|
Enzymes | 1 | 1990 | 261 | 0.020 |
Why?
|
Likelihood Functions | 1 | 2012 | 988 | 0.020 |
Why?
|
Tsetse Flies | 1 | 2008 | 3 | 0.020 |
Why?
|
Opportunistic Infections | 1 | 1991 | 377 | 0.020 |
Why?
|
Staphylococcal Infections | 2 | 1996 | 1405 | 0.020 |
Why?
|
Trypanosoma brucei gambiense | 1 | 2008 | 8 | 0.020 |
Why?
|
Acute Disease | 1 | 1999 | 7268 | 0.020 |
Why?
|
HIV-2 | 1 | 1989 | 156 | 0.020 |
Why?
|
Air Microbiology | 1 | 1988 | 94 | 0.020 |
Why?
|
Autoantibodies | 1 | 2017 | 2119 | 0.020 |
Why?
|
Acetophenones | 1 | 1988 | 53 | 0.020 |
Why?
|
Phthalimides | 1 | 1988 | 34 | 0.020 |
Why?
|
Population Density | 1 | 2008 | 192 | 0.020 |
Why?
|
Hepatitis B | 1 | 1993 | 701 | 0.020 |
Why?
|
Cambodia | 1 | 2008 | 186 | 0.020 |
Why?
|
Double-Blind Method | 1 | 2002 | 12412 | 0.020 |
Why?
|
Ivermectin | 1 | 2007 | 47 | 0.020 |
Why?
|
Risk Assessment | 2 | 2006 | 24086 | 0.020 |
Why?
|
North Carolina | 1 | 2008 | 325 | 0.020 |
Why?
|
Pyridazines | 1 | 1989 | 200 | 0.020 |
Why?
|
Mephenytoin | 1 | 1987 | 3 | 0.020 |
Why?
|
Hydantoins | 1 | 1987 | 12 | 0.020 |
Why?
|
Triglycerides | 2 | 1993 | 2476 | 0.020 |
Why?
|
Bone Cements | 1 | 1988 | 324 | 0.020 |
Why?
|
Malaria Vaccines | 1 | 2008 | 164 | 0.020 |
Why?
|
Guinea Pigs | 1 | 2008 | 1314 | 0.020 |
Why?
|
Evaluation Studies as Topic | 3 | 1998 | 1628 | 0.020 |
Why?
|
Brain Neoplasms | 1 | 2008 | 8984 | 0.020 |
Why?
|
Medicine, East Asian Traditional | 1 | 2006 | 18 | 0.020 |
Why?
|
Virus Diseases | 1 | 1993 | 721 | 0.020 |
Why?
|
Confidence Intervals | 1 | 2012 | 2932 | 0.020 |
Why?
|
Epidemiologic Studies | 1 | 2010 | 670 | 0.020 |
Why?
|
Bacteremia | 1 | 1993 | 979 | 0.020 |
Why?
|
Retrospective Studies | 4 | 2020 | 80301 | 0.020 |
Why?
|
Mass Screening | 1 | 2022 | 5422 | 0.020 |
Why?
|
Maryland | 1 | 2006 | 275 | 0.020 |
Why?
|
Connecticut | 1 | 2006 | 364 | 0.020 |
Why?
|
CD4 Lymphocyte Count | 1 | 2012 | 2569 | 0.020 |
Why?
|
Myositis | 1 | 1988 | 269 | 0.020 |
Why?
|
Epidemiologic Methods | 2 | 1998 | 1344 | 0.020 |
Why?
|
Schistosomiasis mansoni | 1 | 1986 | 94 | 0.020 |
Why?
|
Private Practice | 1 | 2006 | 153 | 0.020 |
Why?
|
Cohort Studies | 2 | 2023 | 41317 | 0.020 |
Why?
|
Biometry | 1 | 2008 | 559 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29636 | 0.020 |
Why?
|
Tuberculosis, Pulmonary | 1 | 1991 | 832 | 0.020 |
Why?
|
Multiple Organ Failure | 1 | 2007 | 387 | 0.020 |
Why?
|
Hepacivirus | 1 | 2012 | 1333 | 0.020 |
Why?
|
Boston | 1 | 1998 | 9282 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2009 | 2473 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 1995 | 5498 | 0.010 |
Why?
|
Bacterial Infections | 1 | 1993 | 1402 | 0.010 |
Why?
|
Rats | 5 | 1994 | 23695 | 0.010 |
Why?
|
Monte Carlo Method | 1 | 2009 | 1256 | 0.010 |
Why?
|
Drug Combinations | 1 | 1989 | 2024 | 0.010 |
Why?
|
Coma | 1 | 2007 | 487 | 0.010 |
Why?
|
Esophageal Diseases | 1 | 1984 | 168 | 0.010 |
Why?
|
Satellite Communications | 1 | 2002 | 13 | 0.010 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2001 | 5644 | 0.010 |
Why?
|
Models, Biological | 2 | 2009 | 9468 | 0.010 |
Why?
|
Parasitic Sensitivity Tests | 1 | 2002 | 88 | 0.010 |
Why?
|
Skin | 1 | 1995 | 4468 | 0.010 |
Why?
|
Specimen Handling | 1 | 2006 | 708 | 0.010 |
Why?
|
Senegal | 1 | 2002 | 256 | 0.010 |
Why?
|
Belize | 1 | 2001 | 15 | 0.010 |
Why?
|
Heart Block | 1 | 1983 | 392 | 0.010 |
Why?
|
Diptera | 1 | 2001 | 50 | 0.010 |
Why?
|
Infection Control | 1 | 2008 | 983 | 0.010 |
Why?
|
India | 1 | 2007 | 2346 | 0.010 |
Why?
|
Intestine, Small | 1 | 1987 | 1207 | 0.010 |
Why?
|
Amyloid beta-Peptides | 1 | 1994 | 3839 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2010 | 2058 | 0.010 |
Why?
|
California | 1 | 2004 | 1416 | 0.010 |
Why?
|
ROC Curve | 1 | 2007 | 3568 | 0.010 |
Why?
|
Merozoite Surface Protein 1 | 1 | 1999 | 37 | 0.010 |
Why?
|
Electrophoresis, Agar Gel | 1 | 1999 | 217 | 0.010 |
Why?
|
Drug Therapy, Combination | 2 | 2007 | 6499 | 0.010 |
Why?
|
Massachusetts | 2 | 1989 | 8805 | 0.010 |
Why?
|
Bayes Theorem | 1 | 2007 | 2325 | 0.010 |
Why?
|
Body Weight | 1 | 1990 | 4613 | 0.010 |
Why?
|
DNA Mutational Analysis | 1 | 2008 | 4109 | 0.010 |
Why?
|
Genes, Protozoan | 1 | 1999 | 166 | 0.010 |
Why?
|
Receptor, Serotonin, 5-HT1D | 1 | 1998 | 9 | 0.010 |
Why?
|
Lipids | 1 | 1990 | 3336 | 0.010 |
Why?
|
Receptor, Serotonin, 5-HT1B | 1 | 1998 | 36 | 0.010 |
Why?
|
Cerebral Palsy | 1 | 1983 | 471 | 0.010 |
Why?
|
Biotransformation | 2 | 1989 | 165 | 0.010 |
Why?
|
Respiratory Insufficiency | 1 | 2007 | 1228 | 0.010 |
Why?
|
Tryptamines | 1 | 1998 | 93 | 0.010 |
Why?
|
Ecosystem | 1 | 2002 | 486 | 0.010 |
Why?
|
Cytokines | 1 | 2013 | 7345 | 0.010 |
Why?
|
Lipid Metabolism | 1 | 1987 | 1902 | 0.010 |
Why?
|
Crohn Disease | 1 | 1991 | 2275 | 0.010 |
Why?
|
Argentina | 1 | 1998 | 245 | 0.010 |
Why?
|
Esophagus | 1 | 1984 | 1023 | 0.010 |
Why?
|
Tissue Distribution | 2 | 1994 | 2262 | 0.010 |
Why?
|
Intestinal Absorption | 2 | 1989 | 401 | 0.010 |
Why?
|
Income | 1 | 2006 | 1876 | 0.010 |
Why?
|
China | 1 | 2003 | 2340 | 0.010 |
Why?
|
Microbial Sensitivity Tests | 1 | 2003 | 1952 | 0.010 |
Why?
|
Injections, Intravenous | 2 | 1989 | 1388 | 0.010 |
Why?
|
Recombinant Proteins | 1 | 2005 | 6543 | 0.010 |
Why?
|
Computer Simulation | 1 | 2009 | 6210 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2006 | 2628 | 0.010 |
Why?
|
Young Adult | 2 | 2013 | 58673 | 0.010 |
Why?
|
Genetic Testing | 1 | 2008 | 3530 | 0.010 |
Why?
|
Spiramycin | 1 | 1994 | 3 | 0.010 |
Why?
|
Immunoglobulin M | 2 | 1994 | 1529 | 0.010 |
Why?
|
Sulfadiazine | 1 | 1994 | 18 | 0.010 |
Why?
|
Canada | 1 | 1999 | 2128 | 0.010 |
Why?
|
Aging | 1 | 1993 | 8641 | 0.010 |
Why?
|
PC12 Cells | 1 | 1994 | 317 | 0.010 |
Why?
|
Intercellular Junctions | 1 | 1994 | 197 | 0.010 |
Why?
|
Chromatography, Thin Layer | 1 | 1993 | 214 | 0.010 |
Why?
|
Epilepsy | 1 | 1988 | 3267 | 0.010 |
Why?
|
Chromatography, Gas | 1 | 1993 | 151 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2011 | 22041 | 0.010 |
Why?
|
Immunohistochemistry | 2 | 1998 | 11064 | 0.010 |
Why?
|
Leucovorin | 1 | 1994 | 639 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2008 | 10434 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 8058 | 0.010 |
Why?
|
Patient Acceptance of Health Care | 1 | 2006 | 3159 | 0.010 |
Why?
|
Bacteriological Techniques | 1 | 1993 | 279 | 0.010 |
Why?
|
Electroencephalography | 1 | 1987 | 6182 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2003 | 2783 | 0.010 |
Why?
|
Disease Progression | 1 | 2008 | 13505 | 0.010 |
Why?
|
Cecal Diseases | 1 | 1991 | 49 | 0.010 |
Why?
|
Liver | 1 | 1987 | 7512 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 1994 | 2558 | 0.010 |
Why?
|
Administration, Oral | 2 | 1989 | 4044 | 0.010 |
Why?
|
Central Nervous System Diseases | 1 | 1994 | 521 | 0.010 |
Why?
|
Chemistry, Physical | 1 | 1989 | 154 | 0.010 |
Why?
|
Staining and Labeling | 1 | 1994 | 1090 | 0.010 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 1989 | 202 | 0.010 |
Why?
|
Chemical Phenomena | 1 | 1989 | 508 | 0.010 |
Why?
|
Africa, Western | 1 | 1989 | 159 | 0.010 |
Why?
|
Suppuration | 1 | 1988 | 61 | 0.010 |
Why?
|
DNA, Bacterial | 1 | 1993 | 1455 | 0.000 |
Why?
|
Retinal Diseases | 1 | 1994 | 702 | 0.000 |
Why?
|
Gallium Radioisotopes | 1 | 1988 | 194 | 0.000 |
Why?
|
Societies, Medical | 1 | 1999 | 3903 | 0.000 |
Why?
|
Solubility | 1 | 1989 | 1088 | 0.000 |
Why?
|
Epitopes | 1 | 1994 | 2506 | 0.000 |
Why?
|
Coronary Vessels | 1 | 1998 | 3112 | 0.000 |
Why?
|
Isomerism | 1 | 1987 | 197 | 0.000 |
Why?
|
Half-Life | 1 | 1988 | 652 | 0.000 |
Why?
|
Radionuclide Imaging | 1 | 1991 | 1975 | 0.000 |
Why?
|
Injections, Intraperitoneal | 1 | 1987 | 413 | 0.000 |
Why?
|
Genetic Predisposition to Disease | 1 | 2008 | 17766 | 0.000 |
Why?
|
Actins | 1 | 1994 | 2049 | 0.000 |
Why?
|
Candidiasis | 1 | 1988 | 364 | 0.000 |
Why?
|
Diagnostic Errors | 1 | 1993 | 1266 | 0.000 |
Why?
|
Transfection | 1 | 1994 | 5782 | 0.000 |
Why?
|
Hepatomegaly | 1 | 1985 | 84 | 0.000 |
Why?
|
Complement Fixation Tests | 1 | 1985 | 71 | 0.000 |
Why?
|
Gastric Mucosa | 1 | 1988 | 599 | 0.000 |
Why?
|
Carbon Dioxide | 1 | 1989 | 1145 | 0.000 |
Why?
|
Splenomegaly | 1 | 1985 | 189 | 0.000 |
Why?
|
Neoplasms | 1 | 1993 | 22066 | 0.000 |
Why?
|
Cell Membrane | 1 | 1994 | 3683 | 0.000 |
Why?
|
Nifurtimox | 1 | 1983 | 14 | 0.000 |
Why?
|
Lipoproteins | 1 | 1987 | 882 | 0.000 |
Why?
|
Immunoenzyme Techniques | 1 | 1985 | 1705 | 0.000 |
Why?
|
Structure-Activity Relationship | 1 | 1987 | 3086 | 0.000 |
Why?
|
Physical Examination | 1 | 1986 | 1244 | 0.000 |
Why?
|
Reference Values | 1 | 1987 | 4920 | 0.000 |
Why?
|
Fibroblasts | 1 | 1989 | 4091 | 0.000 |
Why?
|
Cholesterol | 1 | 1987 | 2925 | 0.000 |
Why?
|
Protein Binding | 1 | 1989 | 9336 | 0.000 |
Why?
|
Mice | 1 | 1987 | 81216 | 0.000 |
Why?
|